Simşek H - Search Results

1

[Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].

Aydoğan S, Ergünay K, Balaban Y, Alp A, Simşek H, Tatar G, Hasçelik G, Us D. Aydoğan S, et al. Among authors: simsek h. Mikrobiyol Bul. 2013 Jul;47(3):472-81. doi: 10.5578/mb.5625. Mikrobiyol Bul. 2013. PMID: 23971924 Free article. Turkish.

2

Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.

Şımşek H, Pinar A, Altinbaş A, Alp A, Balaban YH, Büyükaşik Y, Özcebe O, Hasçelık G, Gedıkoğlu G, Tatar G. Şımşek H, et al. Turk J Gastroenterol. 2012;23(5):569-73. Turk J Gastroenterol. 2012. PMID: 23161303 Free article.

3

[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].

Ergünay K, Kahramanoğlu Aksoy E, Simşek H, Alp A, Sener B, Tatar G, Us D, Hasçelik G. Ergünay K, et al. Among authors: simsek h. Mikrobiyol Bul. 2013 Oct;47(4):628-35. doi: 10.5578/mb.6192. Mikrobiyol Bul. 2013. PMID: 24237431 Free article. Turkish.

4

Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis.

Ergunay K, Balaban Y, Cosgun E, Alp A, Simsek H, Sener B, Tatar G, Hascelik G. Ergunay K, et al. Among authors: simsek h. Ann Hepatol. 2012 Sep-Oct;11(5):672-8. Ann Hepatol. 2012. PMID: 22947528 Free article.

5

Interferon therapy for acute hepatitis C during pregnancy.

Ozaslan E, Yilmaz R, Simsek H, Tatar G. Ozaslan E, et al. Among authors: simsek h. Ann Pharmacother. 2002 Nov;36(11):1715-8. doi: 10.1345/aph.1C065. Ann Pharmacother. 2002. PMID: 12398565 Review.

6

Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population.

Tatar G, Elsurer R, Simsek H, Balaban YH, Hascelik G, Ozcebe OI, Buyukasik Y, Sokmensuer C. Tatar G, et al. Among authors: simsek h. Dig Dis Sci. 2004 Sep;49(9):1479-84. doi: 10.1023/b:ddas.0000042250.59327.91. Dig Dis Sci. 2004. PMID: 15481323

7

Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.

Simsek H, Balaban YH, Yilmaz E, Sumer H, Buyukasik Y, Cengiz C, Ozcebe O, Hascelik G, Tatar G. Simsek H, et al. Ann Hematol. 2005 Oct;84(10):646-9. doi: 10.1007/s00277-005-1048-y. Epub 2005 May 4. Ann Hematol. 2005. PMID: 15871018

8

Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF).

Balaban YH, Sumer H, Simsek H, Us D, Tatar G. Balaban YH, et al. Among authors: simsek h. Ann Hepatol. 2006 Apr-Jun;5(2):109-14. Ann Hepatol. 2006. PMID: 16807517 Free article.

9

What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?

Simsek H, Shorbagi A, Balaban Y, Tatar G. Simsek H, et al. J Hepatol. 2008 Sep;49(3):464-5. doi: 10.1016/j.jhep.2008.06.013. Epub 2008 Jul 3. J Hepatol. 2008. PMID: 18644652 Free article. No abstract available.

10

Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.

Simsek H, Pinar A, Altinbas A, Alp A, Balaban YH, Buyukasik Y, Ozcebe O, Hascelik G, Gedikoglu G, Tatar G. Simsek H, et al. J Clin Lab Anal. 2011;25(4):296-9. doi: 10.1002/jcla.20472. J Clin Lab Anal. 2011. PMID: 21786332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters